Preemption: FDA label preempts state tort law – Bureau of National Affairs responds

Preemption: FDA label preempts state tort law – Bureau of National Affairs responds
In January the Food and Drug Administration issued a new drug labeling rule, stating that its regulation preempts state tort and product liability laws with respect to prescription drugs. The Litigation Group at Bureau of National Affairs, explains why the FDA’s position is legally wrong and bad public policy in the article below.

Download file

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers